Half-year report · HY

Period2025-04-01 → 2025-09-30
Filed2025-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥12.4bn2025-04-01 → 2025-09-30Cons.Net sales
Revenue¥22.5bn2024-04-01 → 2025-03-31Cons.Net sales (5-year summary)
Revenue¥11.4bn2024-04-01 → 2024-09-30Cons.Net sales
Operating income¥1.6bn2025-04-01 → 2025-09-30Cons.Operating income
Operating income¥1.9bn2024-04-01 → 2024-09-30Cons.Operating income
Ordinary income¥1.7bn2025-04-01 → 2025-09-30Cons.Ordinary income
Ordinary income¥3.5bn2024-04-01 → 2025-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.9bn2024-04-01 → 2024-09-30Cons.Ordinary income
Profit before tax¥1.7bn2025-04-01 → 2025-09-30Cons.Income before income taxes
Profit before tax¥2.1bn2024-04-01 → 2024-09-30Cons.Income before income taxes
Net income (owners)¥1.1bn2025-04-01 → 2025-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.2bn2024-04-01 → 2025-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.3bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income¥1.2bn2025-04-01 → 2025-09-30Cons.Profit loss
Net income¥1.5bn2024-04-01 → 2024-09-30Cons.Profit loss
Total assets¥34.9bnat 2025-09-30Cons.Assets
Total assets¥35.4bnat 2025-03-31Cons.Assets
Total assets¥32.6bnat 2024-09-30Cons.Total assets (5-year summary)
Total liabilities¥10.2bnat 2025-09-30Cons.Liabilities
Total liabilities¥9.8bnat 2025-03-31Cons.Liabilities
Net assets / equity¥24.7bnat 2025-09-30Cons.Net assets
Net assets / equity¥25.5bnat 2025-03-31Cons.Net assets
Net assets / equity¥24.4bnat 2024-09-30Cons.Net assets (5-year summary)
Cash and deposits¥13.7bnat 2025-09-30Cons.Cash and deposits
Cash and deposits¥15.4bnat 2025-03-31Cons.Cash and deposits
Cash & equivalents¥13.7bnat 2025-09-30Cons.Cash and cash equivalents
Cash & equivalents¥15.4bnat 2025-03-31Cons.Cash and cash equivalents
Cash & equivalents¥15.7bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥14.0bnat 2024-03-31vCons.Cash and cash equivalents
Operating cash flow¥1.4bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥2.7bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.2bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥998m2025-04-01 → 2025-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥1.9bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥1.1bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥1.9bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in financing activities
Financing cash flow¥553m2024-04-01 → 2025-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥703m2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥145.462025-04-01 → 2025-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥292.412024-04-01 → 2025-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥170.42024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio66.4%at 2025-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio67.8%at 2025-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio70.3%at 2024-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
Medical Relatedreportable segmentrevenue2025-04-01 → 2025-09-30¥1.5bn
Medical Relatedreportable segmentrevenue external2025-04-01 → 2025-09-30¥1.5bn
Medical Relatedreportable segmentsegment profit2025-04-01 → 2025-09-30¥108m
Water Health Carereportable segmentrevenue2025-04-01 → 2025-09-30¥10.9bn
Water Health Carereportable segmentrevenue external2025-04-01 → 2025-09-30¥10.9bn
Water Health Carereportable segmentsegment profit2025-04-01 → 2025-09-30¥1.5bn
—segment totalrevenue2025-04-01 → 2025-09-30¥12.4bn
—segment totalrevenue external2025-04-01 → 2025-09-30¥12.4bn
—segment totalsegment profit2025-04-01 → 2025-09-30¥1.6bn
Medical Relatedreportable segmentrevenue2024-04-01 → 2024-09-30¥1.4bn
Medical Relatedreportable segmentrevenue external2024-04-01 → 2024-09-30¥1.4bn
Medical Relatedreportable segmentsegment profit2024-04-01 → 2024-09-30¥215m
Water Health Carereportable segmentrevenue2024-04-01 → 2024-09-30¥9.9bn
Water Health Carereportable segmentrevenue external2024-04-01 → 2024-09-30¥9.9bn
Water Health Carereportable segmentsegment profit2024-04-01 → 2024-09-30¥1.6bn
—segment totalrevenue2024-04-01 → 2024-09-30¥11.4bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥11.4bn
—segment totalsegment profit2024-04-01 → 2024-09-30¥1.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 518
ItemContextValueUnit
Other net ope cfPrior1InterimDuration15032000JPY
Other net ope cfInterimDuration125746000JPY
Subtotal ope cfPrior1InterimDuration1849623000JPY
Subtotal ope cfInterimDuration1853893000JPY
Interest and dividends income received ope cf inv cfPrior1InterimDuration30622000JPY
Interest and dividends income received ope cf inv cfInterimDuration53243000JPY
Interest expenses paid ope cf fin cfPrior1InterimDuration-787000JPY
Interest expenses paid ope cf fin cfInterimDuration-2660000JPY
Income taxes paid ope cfPrior1InterimDuration-703950000JPY
Income taxes paid ope cfInterimDuration-493770000JPY
Net cash provided by used in operating activitiesPrior1InterimDuration1175508000JPY
Net cash provided by used in operating activitiesInterimDuration1410706000JPY
Proceeds from withdrawal of time deposits inv cfPrior1InterimDuration500000000JPY
Proceeds from withdrawal of time deposits inv cfInterimDuration-JPY
Proceeds from redemption of securities inv cfPrior1InterimDuration1000000000JPY
Proceeds from redemption of securities inv cfInterimDuration500000000JPY
Purchase of property plant and equipment inv cfPrior1InterimDuration-171341000JPY
Purchase of property plant and equipment inv cfInterimDuration-298458000JPY
Proceeds from sales of property plant and equipment inv cfPrior1InterimDuration18045000JPY
Proceeds from sales of property plant and equipment inv cfInterimDuration21347000JPY
Purchase of intangible assets inv cfPrior1InterimDuration-34513000JPY
Purchase of intangible assets inv cfInterimDuration-79167000JPY
Purchase of stocks of subsidiaries and affiliates inv cfPrior1InterimDuration-JPY
Purchase of stocks of subsidiaries and affiliates inv cfInterimDuration-374161000JPY
Purchase of investment securities inv cfPrior1InterimDuration-400000000JPY
Purchase of investment securities inv cfInterimDuration-700000000JPY
Proceeds from sales of investment securities inv cfPrior1InterimDuration203024000JPY
Proceeds from sales of investment securities inv cfInterimDuration-JPY
Purchase of insurance funds inv cfPrior1InterimDuration-14822000JPY
Purchase of insurance funds inv cfInterimDuration-105061000JPY
Other net inv cfPrior1InterimDuration23500000JPY
Other net inv cfInterimDuration37585000JPY
Net cash provided by used in investment activitiesPrior1InterimDuration1123893000JPY
Net cash provided by used in investment activitiesInterimDuration-997915000JPY
Repayment of long term loans payable fin cfPrior1InterimDuration-JPY
Repayment of long term loans payable fin cfInterimDuration-62264000JPY
Purchase of treasury stock fin cfPrior1InterimDuration-349000JPY
Purchase of treasury stock fin cfInterimDuration-695018000JPY
Proceeds from disposal of treasury stock fin cfPrior1InterimDuration-JPY
Proceeds from disposal of treasury stock fin cfInterimDuration43544000JPY
Cash dividends paid fin cfPrior1InterimDuration-687204000JPY
Cash dividends paid fin cfInterimDuration-1072892000JPY
Purchase of treasury stock of subsidiaries in consolidation fin cfPrior1InterimDuration-JPY
Purchase of treasury stock of subsidiaries in consolidation fin cfInterimDuration-106008000JPY
Other net fin cfPrior1InterimDuration-15075000JPY
Other net fin cfInterimDuration-10659000JPY
Net cash provided by used in financing activitiesPrior1InterimDuration-702630000JPY
Net cash provided by used in financing activitiesInterimDuration-1903298000JPY
Effect of exchange rate change on cash and cash equivalentsPrior1InterimDuration102779000JPY
Effect of exchange rate change on cash and cash equivalentsInterimDuration-155396000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2025-03-31pass
balance sheet identityconsolidated 2025-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2025-03-31pass
statement vs summary · net assetsconsolidated 2025-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2025-04-01/2025-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2025-04-01/2025-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2025-04-01/2025-09-30pass
statement vs summary · total assetsconsolidated 2025-03-31pass
statement vs summary · total assetsconsolidated 2025-09-30pass